This is a proposal to support career development for up to five senior fellows or junior faculty members in clinical cancer research at the Dana-Farber/Harvard Cancer Center, a consortium of Harvard Medical School (HMS), Harvard School of Public Health, and the primary HMS teaching hospitals -- Dana-Farber Cancer Institute, Massachusetts General Hospital, Brigham and Women?s Hospital, The Children?s Hospital and Beth Israel Deaconess Hospital.
The aim of this proposal is to address the need for physician scientists capable of translating the most promising discoveries of molecular genetics and biology, drug discovery, epidemiology, and psychosocial research into useful application in cancer patients. We propose to select five physicians or nurses at the level of Senior Research Fellow, Instructor or Assistant Professor in subspecialties of surgical, radiation, pediatric, medical, and nursing oncology, for a maximum of five years of support. Their career development plan will include didactic course work in clinical trial design and management, and formal hands-on training in important technologies related to their field of interest, as well as mentored research involving clinical trials. Candidates may pursue laboratory training related to clinical trials, such as genetics, pharmacokinetics, or clinical immunology as part of their career development plan. Each candidate will design and manage a clinical research trial as part of his/her grant-supported effort. Women and minority candidates will be encouraged to apply for this award. Mentors for the laboratory, clinical, and biostatistical aspects of the candidate?s work will be an integral part of the training plan. An advisory committee of faculty drawn from the major cancer specialties, basic science, epidemiology, and biostatistics will select candidates, supervise their progress, and evaluate the effectiveness of their training, research, and mentoring. The advisory committee will also be responsible for evaluating the overall effectiveness of the program and identifying opportunities for new areas of emphasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
5K12CA087723-03
Application #
6772698
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lei, Ming
Project Start
2002-09-27
Project End
2007-06-30
Budget Start
2004-09-01
Budget End
2005-06-30
Support Year
3
Fiscal Year
2004
Total Cost
$676,755
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Bardia, Aditya; Gucalp, Ayca; DaCosta, Noashir et al. (2018) Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer. Breast Cancer Res Treat :
Spring, Laura; Niemierko, Andrzej; Haddad, Stephanie et al. (2018) Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer. Breast Cancer Res Treat 172:733-740
Farago, Anna F; Taylor, Martin S; Doebele, Robert C et al. (2018) Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion. JCO Precis Oncol 2018:
El-Jawahri, Areej; Fishman, Sarah R; Vanderklish, Julie et al. (2018) Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation. Cancer 124:2438-2446
Aceto, Nicola; Bardia, Aditya; Wittner, Ben S et al. (2018) AR Expression in Breast Cancer CTCs Associates with Bone Metastases. Mol Cancer Res 16:720-727
El-Jawahri, Areej; LeBlanc, Thomas W; Burns, Linda J et al. (2018) What do transplant physicians think about palliative care? A national survey study. Cancer 124:4556-4566
Kennedy, James A; Hobbs, Gabriela (2018) Tyrosine Kinase Inhibitors in the Treatment of Chronic-Phase CML: Strategies for Frontline Decision-making. Curr Hematol Malig Rep 13:202-211
Franses, Joseph W; Basar, Omer; Kadayifci, Abdurrahman et al. (2018) Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms. Oncologist 23:121-127
Kwan, Tanya T; Bardia, Aditya; Spring, Laura M et al. (2018) A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer. Cancer Discov 8:1286-1299
El-Jawahri, Areej; Traeger, Lara; Shin, Jennifer A et al. (2017) Qualitative Study of Patients' and Caregivers' Perceptions and Information Preferences About Hospice. J Palliat Med 20:759-766

Showing the most recent 10 out of 125 publications